Sort by
Refine Your Search
-
to define how RecQ helicases maintain genome stability to limit premature aging and cancer development. These projects will benefit from access to cutting-edge mass spectrometry, imaging, screening and
-
single-cell sequencing, genetic perturbation, and advanced spatial methods (including smFISH, light-sheet imaging, and whole-brain clearing). This project builds on our expertise in gene regulatory
-
nanotechnology to one of the most pressing medical challenges - this is your place. About the research group You will join the Biomimetics, Biocarriers and Bioimplants group (The 3Bs), led by Associate Professor
-
nanotechnology to one of the most pressing medical challenges—this is your place. About the research group You will join the Biomimetics, Biocarriers and Bioimplants group (The 3Bs), led by Associate Professor
-
) quantification tools, holding back early immunogenicity risk assessment in the context of protein drug development. A clearer understanding of the rules governing T cell activation would form a paradigm shift in
-
paradigm shift in development of Biologics. A critical challenge preventing this is the current limiting volume of high quality and well-characterized in-vitro T cell immunogenicity data. In this project, we
-
affiliated with the team of Associate Professor Chiara Francavilla in the Section for Medical Biotechnology at the Department of Biotechnology and Biomedicine, Technical University of Denmark. The successful
-
. Application procedure Your complete online application must be submitted no later than 21 March 2025 (23:59 Danish time). Apply online here: Postdoc in T Cell Immunoinformatics Applications must be submitted as